Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
International Immunopharmacology|October 16, 2023
Mycobacterium tuberculosis suppresses APLP2 expression to enhance its survival in macrophageJianxia Chen, Fen Tang, Haohao Li, et al.
Cell Death and Differentiation|April 25, 2026
Endothelial USP2a-METTL16 loop potentiates IL-6 signaling via m6A-mediated IL-6R stabilization in pulmonary vascular remodelingHanqing Zhu, Ping Yuan, Xiangyang Wu, et al.
Cell Death & Disease|November 1, 2025
Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancerMengge Zheng, Su Hang, Changyong Hu, et al.
Cell Reports|April 18, 2025
Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunityYifang Dang, Mingtong Ma, Yan Wang, et al.
International Journal of Environmental Research and Public Health|September 25, 2014
Community knowledge and experience of mosquitoes and personal prevention and control practices in Lhasa, TibetXiaobo Liu, Fangjun Wan, Cirendunzhu, et al.
The Journal of Prevention of Alzheimer'S Disease|February 28, 2026
Prevention of dementia using mobile phone applications (PRODEMOS) - a health-economic cost-utility analysis in people aged 55-75 years with low socio-economic statusRon Handels, Marieke Hoevenaar-Blom, Manshu Song, et al.
Cell Research|January 5, 2025
Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responsesQihang Zhao, Qiang Wang, Qinghua Yao, et al.
Journal of Gastroenterology and Hepatology|July 5, 2014
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infectionRichard A Colvin, Tawesak Tanwandee, Teerha Piratvisuth, et al.
Elife|November 4, 2024
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growthLianhua Qin, Junfang Xu, Jianxia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
First-in-human HER2-targeted Bispecific Antibody KN026 for the Treatment of Patients with HER2-positive Metastatic Breast Cancer: Results from a Phase I StudyJian Zhang, Dongmei Ji, Li Cai, et al.
Pageof 10